MERIT MEDICAL SYSTEMS INCMMSI财报
Nasdaq · 医疗保健 · 外科及医疗仪器和设备
梅里特医疗系统公司是一家全球性医疗设备企业，设计、生产和销售适用于心脏病学、放射学、肿瘤学、内窥镜及重症监护领域的介入和诊断产品，为全球医院及医疗机构提供微创医疗解决方案，助力提升患者疗效和临床操作效率。
MMSI Q4 2025 Key Financial Metrics
营收
$393.9M
毛利润
$195.4M
营业利润
$54.2M
净利润
$38.0M
毛利率
49.6%
营业利润率
13.8%
净利率
9.6%
同比增长
10.9%
EPS
$0.64
资金流向
MERIT MEDICAL SYSTEMS INC Q4 2025 财务摘要
MERIT MEDICAL SYSTEMS INC Q4 2025营收 $393.9M（同比增长 10.9%），净利润 $38.0M（同比增长 36.0%）（净利率 9.6%）。销售成本 $198.6M，运营费用 $141.2M。
核心财务指标
| 总营收 | $393.9M |
|---|---|
| 净利润 | $38.0M |
| 毛利率 | 49.6% |
| 营业利润率 | 13.8% |
| 报告期 | Q4 2025 |
营收拆解
MERIT MEDICAL SYSTEMS INC Q4 2025营收 $393.9M 共来自 6 个业务板块，最大板块 Other 贡献 $154.6M（占 39.2%）。
| 业务分部 | 营收 | 占比 |
|---|---|---|
| Other | $154.6M | 39.2% |
| Peripheral Intervention | $93.2M | 23.7% |
| Cardiac Intervention | $50.2M | 12.8% |
| OEM | $42.6M | 10.8% |
| Custom Procedural Solutions | $33.1M | 8.4% |
| Endoscopy Segment | $20.1M | 5.1% |
MERIT MEDICAL SYSTEMS INC 分部营收 — 季度趋势
MERIT MEDICAL SYSTEMS INC 过去 4 个季度各业务板块营收走势，展示 Other and Peripheral Intervention 等业务的变化。
| 业务分部 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Other | $154.6M | $135.8M | $136.9M | $109.3M |
| Peripheral Intervention | $93.2M | $84.5M | $84.0M | $80.2M |
| Cardiac Intervention | $50.2M | $49.6M | $46.1M | $41.4M |
| OEM | $42.6M | $46.1M | $46.9M | $47.0M |
| Custom Procedural Solutions | $33.1M | $33.5M | $32.7M | $29.2M |
MERIT MEDICAL SYSTEMS INC 年度营收
MERIT MEDICAL SYSTEMS INC 历年营收汇总，含各年度总量（例如 2025 年营收为 $1.5B）。点击带链接的年份，查看该年度相比前一年的财报变化。
MERIT MEDICAL SYSTEMS INC 季度营收与净利润历史
MERIT MEDICAL SYSTEMS INC 最近 8 个季度的营收、净利润及同比增速
| 季度 | 营收 | 营收同比 | 净利润 | 净利率 |
|---|---|---|---|---|
| Q4 2025 | $393.9M | +10.9% | $38.0M | 9.6% |
| Q3 2025 | $384.2M | +13.0% | $27.8M | 7.2% |
| Q2 2025 | $382.5M | +13.2% | $32.6M | 8.5% |
| Q1 2025 | $355.4M | +9.8% | $30.1M | 8.5% |
| Q4 2024 | $355.2M | +9.4% | $27.9M | 7.9% |
| Q3 2024 | $339.8M | +7.8% | $28.4M | 8.4% |
| Q2 2024 | $338.0M | +5.6% | $35.7M | 10.6% |
| Q1 2024 | $323.5M | +8.7% | $28.2M | 8.7% |
利润表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 营收 | $323.5M | $338.0M | $339.8M | $355.2M | $355.4M | $382.5M | $384.2M | $393.9M |
| 同比增长 | 8.7% | 5.6% | 7.8% | 9.4% | 9.8% | 13.2% | 13.0% | 10.9% |
资产负债表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 总资产 | $2.33B | $2.37B | $2.38B | $2.42B | $2.47B | $2.59B | $2.63B | $2.69B |
| 总负债 | $1.09B | $1.09B | $1.05B | $1.04B | $1.04B | $1.10B | $1.10B | $1.10B |
| 股东权益 | $1.24B | $1.28B | $1.32B | $1.38B | $1.43B | $1.49B | $1.53B | $1.58B |
现金流量表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 经营性现金流 | $36.2M | $68.5M | $47.3M | $68.7M | $40.6M | $83.3M | $75.0M | $98.5M |